INDIGO Biosciences, Inc. today announced it has entered into a distribution agreement with Cayman Chemical Company. Cayman will be promoting and distributing INDIGOâ€™s nuclear receptor assay kits and screening services worldwide.
Online PR News – 24-February-2014 – State College, PA – State College, PA (February 24, 2014) â€“ INDIGO Biosciences, Inc. today announced it has entered into a distribution agreement with Cayman Chemical Company. Cayman will be promoting and distributing INDIGOâ€™s nuclear receptor assay kits and screening services worldwide. This agreement will position INDIGO to attract more customers, increase their market share and sell its products and services on a global basis.
INDIGO Biosciences is the only contract research services company focused exclusively on nuclear receptor screening, offering a comprehensive menu of nuclear receptor screening services as well as nonhuman nuclear receptor assays, functional assays and custom assay development.
In addition to their on-site contract screening services, INDIGO Biosciences brings their nuclear receptor expertise directly into their clientâ€™s lab with easy-to-use assay kits. Each kit includes reporter cells, assay plates and all reagents for both 96 and 384 well formats. Their assay products feature engineered reporter cells prepared using INDIGOâ€™s CryoMiteâ„˘ process. Once thawed, cells are ready for immediate use and typically present >95% viability. Test compounds may be screened for agonist or antagonist activities against human nuclear receptors expressed within healthy, dividing mammalian cells.
â€śWe are very excited to work with Cayman Chemical,â€ť said Fred Marroni, CEO, of INDIGO Biosciences. â€śTeaming up with Cayman Chemical will allow us to expand market awareness and service our customers on a global basis.â€ť
â€śINDIGO Biosciences is a great partner and this agreement supports our mission of supplying scientists worldwide with the research tools necessary for advancing human and animal health. Our real commitment to life science researchers is to offer the highest quality products with affordable pricing,â€ť said Dr. Kirk Maxey, President & CEO, of Cayman Chemical.
About INDIGO Biosciences
INDIGO Biosciences, Inc. was founded in 2005 in State College, PA. It remains a privately held biosciences company offering products and services focused on nuclear receptors to the Pharmaceutical, Biotechnology, Environmental and Nutraceutical market. INDIGO provides high-quality, confidential screening services and assay kits for drug discovery and toxicology research. For more information visit their website at www.indigobiosciences.com.
About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Cayman specializes in assay kits for the measurement of hormones and bio-markers. In addition, Cayman offers a broad range of specialty biochemicals used as research reagents and qualified standards. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic. Cayman employs approximately 300 people worldwide.
For more information on INDIGO Biosciences, Inc. please visit our website at www.indigobiosciences.com or give us a call at (814) 234-1919.